IL194468A - מכשיר לבדיקה תוך–גופית - Google Patents
מכשיר לבדיקה תוך–גופיתInfo
- Publication number
- IL194468A IL194468A IL194468A IL19446808A IL194468A IL 194468 A IL194468 A IL 194468A IL 194468 A IL194468 A IL 194468A IL 19446808 A IL19446808 A IL 19446808A IL 194468 A IL194468 A IL 194468A
- Authority
- IL
- Israel
- Prior art keywords
- imaging device
- nano
- liposomes
- vivo
- substance
- Prior art date
Links
- 238000011503 in vivo imaging Methods 0.000 title claims description 11
- 239000002502 liposome Substances 0.000 claims description 82
- 239000000126 substance Substances 0.000 claims description 38
- 230000003287 optical effect Effects 0.000 claims description 31
- 239000000463 material Substances 0.000 claims description 28
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 238000003384 imaging method Methods 0.000 claims description 15
- 230000008859 change Effects 0.000 claims description 10
- 239000012491 analyte Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000017 hydrogel Substances 0.000 claims description 6
- 239000003550 marker Substances 0.000 claims description 6
- 238000005286 illumination Methods 0.000 claims description 4
- 239000002250 absorbent Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 229920001059 synthetic polymer Polymers 0.000 claims description 3
- 230000002745 absorbent Effects 0.000 claims description 2
- 229920006037 cross link polymer Polymers 0.000 claims description 2
- 239000002612 dispersion medium Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 239000000693 micelle Substances 0.000 claims description 2
- 229920005615 natural polymer Polymers 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 description 53
- 230000011664 signaling Effects 0.000 description 22
- 239000000427 antigen Substances 0.000 description 17
- 102000036639 antigens Human genes 0.000 description 17
- 108091007433 antigens Proteins 0.000 description 17
- 238000000034 method Methods 0.000 description 16
- 230000004048 modification Effects 0.000 description 15
- 238000012986 modification Methods 0.000 description 15
- 206010028980 Neoplasm Diseases 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 238000012545 processing Methods 0.000 description 9
- 210000001035 gastrointestinal tract Anatomy 0.000 description 8
- 230000007170 pathology Effects 0.000 description 8
- 239000000376 reactant Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 208000037062 Polyps Diseases 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000000737 periodic effect Effects 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 102000057297 Pepsin A Human genes 0.000 description 3
- 108090000284 Pepsin A Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 102400000921 Gastrin Human genes 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229920000575 polymersome Polymers 0.000 description 2
- 210000005000 reproductive tract Anatomy 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- ZPLCXHWYPWVJDL-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)methyl]-1,3-oxazolidin-2-one Chemical compound C1=CC(O)=CC=C1CC1NC(=O)OC1 ZPLCXHWYPWVJDL-UHFFFAOYSA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 241001553178 Arachis glabrata Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- -1 e.g. Polymers 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 108010066264 gastrin 17 Proteins 0.000 description 1
- GKDWRERMBNGKCZ-RNXBIMIWSA-N gastrin-17 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 GKDWRERMBNGKCZ-RNXBIMIWSA-N 0.000 description 1
- 239000012216 imaging agent Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
Landscapes
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL194468A IL194468A (he) | 2006-04-03 | 2008-10-02 | מכשיר לבדיקה תוך–גופית |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78811406P | 2006-04-03 | 2006-04-03 | |
| PCT/IL2007/000458 WO2007113839A2 (en) | 2006-04-03 | 2007-04-10 | Device, system and method for in-vivo analysis |
| IL194468A IL194468A (he) | 2006-04-03 | 2008-10-02 | מכשיר לבדיקה תוך–גופית |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL194468A0 IL194468A0 (en) | 2011-08-01 |
| IL194468A true IL194468A (he) | 2012-12-31 |
Family
ID=44671847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL194468A IL194468A (he) | 2006-04-03 | 2008-10-02 | מכשיר לבדיקה תוך–גופית |
Country Status (1)
| Country | Link |
|---|---|
| IL (1) | IL194468A (he) |
-
2008
- 2008-10-02 IL IL194468A patent/IL194468A/he active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| IL194468A0 (en) | 2011-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2007433B1 (en) | Device, system and method for in-vivo analysis | |
| US8738106B2 (en) | Device, system and method for in vivo analysis | |
| US20100322866A1 (en) | Device, system and method for in-vivo analysis | |
| US8249681B2 (en) | Device, system and method for in vivo analysis | |
| EP2382463B1 (en) | Device,system and method for detection of bleeding | |
| CN103827668B (zh) | 用于体内免疫测定的装置、系统和方法 | |
| US8290556B2 (en) | Device, system and method for in-vivo analysis | |
| EP1534120B1 (en) | System for in vivo sampling and analysis | |
| US7901366B2 (en) | System and method for determining in vivo body lumen conditions | |
| US7938775B2 (en) | Device, system, and method for in-vivo analysis | |
| AU2002225316A1 (en) | A system and method for determining in vivo body lumen conditions | |
| US20050137468A1 (en) | Device, system, and method for in-vivo sensing of a substance | |
| EP2838415A1 (en) | Light emitting diode endoscopic devices for visualization of diseased tissue in humans and animals | |
| WO2009057120A2 (en) | Device, system and method for in-vivo analysis | |
| IL205462A (he) | מכשיר, מערכת ושיטה לבדיקה תוך גופית | |
| IL156962A (he) | מערכת ושיטה לקביעת מצב החללים בגוף החי |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |